Nova Leap Health (NLH) Investor presentation summary
Event summary combining transcript, slides, and related documents.
Investor presentation summary
1 May, 2026Industry overview and growth drivers
Home care is among the fastest growing healthcare sectors in the U.S., fueled by an aging population, chronic disease prevalence, and a shift toward cost-efficient care options.
The at-home care industry is projected to grow at a 4.9% CAGR from 2020 to 2026, with non-medical home care representing 6.4% of the U.S. total.
By 2030, over 20% of Americans are expected to be over 65, increasing demand for home care services.
Dementia care is a significant revenue driver, accounting for about 70% of revenue.
Socioeconomic trends are reducing the availability of family caregivers, further boosting industry demand.
Business model and strategy
Focuses on acquiring and organically growing home care companies, offering both non-medical and skilled home care services.
Revenue is primarily out-of-pocket, reducing reimbursement risk compared to government-funded home health care.
Operates in 10 U.S. states and Nova Scotia, Canada, with a decentralized local management model supported by centralized back office.
Growth strategy includes organic expansion, targeted acquisitions, and joint venture partnerships to enhance service quality and margins.
Acquisition targets are typically profitable, established companies with $1M–$25M revenue and strong reputations.
Financial performance and position
Achieved record adjusted EBITDA of $1.6M in 2024, with increasing gross margins indicating pricing power.
Amended credit agreement in Q4 2024, providing up to $7M in available credit; $4.7M available as of May 2025.
Available cash of $1.3M USD and full access to a CAD $1.5M revolving credit facility at Q1 2025.
Total bank debt and promissory notes of $2.5M at Q1 2025, with a leverage ratio of 1.70x adjusted EBITDA.
Consistent revenue and EBITDA growth since 2017, with annual revenue reaching $28.2M in 2024.
Latest events from Nova Leap Health
- Record revenue and EBITDA growth in 2025, with robust margins and strong liquidity.NLH
Q4 20256 Mar 2026 - Profitable in-home care provider grows via acquisitions, targeting long-term, sustainable expansion.NLH
Presents at Planet MicroCap Showcase: VEGAS 202524 Nov 2025 - Record Q3 2025 revenue and profitability, with both segments achieving all-time highs.NLH
Q3 202518 Nov 2025 - Record revenue and margin growth in Q2 2025, with strong segment and operational performance.NLH
Q2 202519 Aug 2025 - Nova Leap Health accelerates growth in home care with record EBITDA and strategic acquisitions.NLH
Investor Presentation13 Jun 2025 - 10th consecutive positive Adjusted EBITDA, strong cash, and new acquisition despite revenue dip.NLH
Q2 202413 Jun 2025 - Q3 2024 delivered consistent operating results and sets up Nova Leap for further acquisitive growth.NLH
Q3 202413 Jun 2025 - Revenue up 10.3% YoY, but profit metrics down; Nova Scotia leads growth.NLH
Q1 20256 Jun 2025 - Record Adjusted EBITDA and strategic acquisitions drive Nova Leap's growth in 2024.NLH
Q4 20246 Jun 2025